| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bevacizumab in the Treatment of a Patient with Metastatic Colorectal Carcinoma with Brain Metastases
|
Bhaskara, Achala
|
|
2008
|
7 |
1 |
p. 65-68
4 p.
|
artikel
|
| 2 |
Clinical Colorectal Cancer: Targeted Therapy in 2008
|
Chu, Edward
|
|
2008
|
7 |
1 |
p. 6-
1 p.
|
artikel
|
| 3 |
Current Status of Chemotherapy for Advanced Colorectal Cancer in Japan
|
Yamada, Yasuhide
|
|
2008
|
7 |
1 |
p. 15-24
10 p.
|
artikel
|
| 4 |
Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
|
Racca, Patrizia
|
|
2008
|
7 |
1 |
p. 48-54
7 p.
|
artikel
|
| 5 |
Epidermal Growth Factor Receptor Inhibitor–Related Skin Toxicity: Mechanisms, Treatment, and its Potential Role as a Predictive Marker
|
Bianchini, Diletta
|
|
2008
|
7 |
1 |
p. 33-43
11 p.
|
artikel
|
| 6 |
Oxaliplatin in Combination with 5-Fluorouracil/Leucovorin or Capecitabine in Elderly Patients with Metastatic Colorectal Cancer
|
Arkenau, Hendrik-Tobias
|
|
2008
|
7 |
1 |
p. 60-64
5 p.
|
artikel
|
| 7 |
Phase II Trial of T138067, a Novel Microtubule Inhibitor, in Patients with Metastatic, Refractory Colorectal Carcinoma
|
Berlin, Jordan D.
|
|
2008
|
7 |
1 |
p. 44-47
4 p.
|
artikel
|
| 8 |
Second-Line Chemotherapy Use in Metastatic Colon Cancer Varies by Disease Responsiveness
|
Politano, Seth
|
|
2008
|
7 |
1 |
p. 55-59
5 p.
|
artikel
|
| 9 |
Second-Line Management of Metastatic Colorectal Cancer
|
Gallagher, David J.
|
|
2008
|
7 |
1 |
p. 25-32
8 p.
|
artikel
|
| 10 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2008
|
7 |
1 |
p. 69-
1 p.
|
artikel
|
| 11 |
Triplet Combination of Fluoropyrimidines, Oxaliplatin, and Irinotecan in the First-Line Treatment of Metastatic Colorectal Cancer
|
Masi, Gianluca
|
|
2008
|
7 |
1 |
p. 7-14
8 p.
|
artikel
|
Tijdschrift beschrijving